1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
2
|
Ficarra V, Galfano A, Novara G, Iafrate M,
Brunelli M, Secco S, Cavalleri S, Martignoni G and Artibani W: Risk
stratification and prognostication of renal cell carcinoma. World J
Urol. 26:115–125. 2008. View Article : Google Scholar : PubMed/NCBI
|
3
|
Kim SP, Alt AL, Weight CJ, Costello BA,
Cheville JC, Lohse C, Allmer C and Leibovich BC: Independent
validation of the 2010 American Joint Committee on Cancer TNM
classification for renal cell carcinoma: Results from a large,
single institution cohort. J Urol. 185:2035–2039. 2011. View Article : Google Scholar : PubMed/NCBI
|
4
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Sorbellini M, Kattan MW, Snyder ME, Reuter
V, Motzer R, Goetzl M, McKiernan J and Russo P: A postoperative
prognostic nomogram predicting recurrence for patients with
conventional clear cell renal cell carcinoma. J Urol. 173:48–51.
2005. View Article : Google Scholar : PubMed/NCBI
|
6
|
Bowles J, Schepers G and Koopman P:
Phylogeny of the SOX family of developmental transcription factors
based on sequence and structural indicators. Dev Biol. 227:239–255.
2000. View Article : Google Scholar : PubMed/NCBI
|
7
|
Castillo SD and Sanchez-Cespedes M: The
SOX family of genes in cancer development: Biological relevance and
opportunities for therapy. Expert Opin Ther Targets. 16:903–919.
2012. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kamachi Y and Kondoh H: Sox proteins:
Regulators of cell fate specification and differentiation.
Development. 140:4129–4144. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Castillo SD, Matheu A, Mariani N,
Carretero J, Lopez-Rios F, Lovell-Badge R and Sanchez-Cespedes M:
Novel transcriptional targets of the SRY-HMG box transcription
factor SOX4 link its expression to the development of small cell
lung cancer. Cancer Res. 72:176–186. 2012. View Article : Google Scholar : PubMed/NCBI
|
10
|
Chapman CJ, Thorpe AJ, Murray A,
Parsy-Kowalska CB, Allen J, Stafford KM, Chauhan AS, Kite TA,
Maddison P and Robertson JF: Immunobiomarkers in small cell lung
cancer: Potential early cancer signals. Clin Cancer Res.
17:1474–1480. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
De la Rocha AM, Sampron N, Alonso MM and
Matheu A: Role of SOX family of transcription factors in central
nervous system tumors. Am J Cancer Res. 4:312–324. 2014.PubMed/NCBI
|
12
|
Liao YL, Sun YM, Chau GY, Chau YP, Lai TC,
Wang JL, Horng JT, Hsiao M and Tsou AP: Identification of SOX4
target genes using phylogenetic footprinting-based prediction from
expression microarrays suggests that overexpression of SOX4
potentiates metastasis in hepatocellular carcinoma. Oncogene.
27:5578–5589. 2008. View Article : Google Scholar : PubMed/NCBI
|
13
|
Sashikawa Kimura M, Mutoh H and Sugano K:
SOX9 is expressed in normal stomach, intestinal metaplasia, and
gastric carcinoma in humans. J Gastroenterol. 46:1292–1299. 2011.
View Article : Google Scholar : PubMed/NCBI
|
14
|
Matheu A, Collado M, Wise C, Manterola L,
Cekaite L, Tye AJ, Canamero M, Bujanda L, Schedl A, Cheah KS, et
al: Oncogenicity of the developmental transcription factor Sox9.
Cancer Res. 72:1301–1315. 2012. View Article : Google Scholar : PubMed/NCBI
|
15
|
Malki S, Bibeau F, Notarnicola C, Roques
S, Berta P, Poulat F and Boizet-Bonhoure B: Expression and
biological role of the prostaglandin D synthase/SOX9 pathway in
human ovarian cancer cells. Cancer Lett. 255:182–193. 2007.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Lu X, Wan F, Zhang H, Shi G and Ye D:
ITGA2B and ITGA8 are predictive of prognosis in clear cell renal
cell carcinoma patients. Tumour Biol. 37:253–262. 2016. View Article : Google Scholar : PubMed/NCBI
|
17
|
Buttner F, Winter S, Rausch S, Reustle A,
Kruck S, Junker K, Stenzl A, Agaimy A, Hartmann A, Bedke J, et al:
Survival prediction of clear cell renal cell carcinoma based on
gene expression similarity to the proximal tubule of the nephron.
Eur Urol. 68:1016–1020. 2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Garraway LA and Sellers WR: Lineage
dependency and lineage-survival oncogenes in human cancer. Nat Rev
Cancer. 6:593–602. 2006. View
Article : Google Scholar : PubMed/NCBI
|
20
|
Lengerke C, Fehm T, Kurth R, Neubauer H,
Scheble V, Müller F, Schneider F, Petersen K, Wallwiener D, Kanz L,
et al: Expression of the embryonic stem cell marker SOX2 in
early-stage breast carcinoma. BMC Cancer. 11:422011. View Article : Google Scholar : PubMed/NCBI
|
21
|
Neumann J, Bahr F, Horst D, Kriegl L,
Engel J, Luque RM, Gerhard M, Kirchner T and Jung A: SOX2
expression correlates with lymph-node metastases and distant spread
in right-sided colon cancer. BMC Cancer. 11:5182011. View Article : Google Scholar : PubMed/NCBI
|
22
|
Lundberg IV, Löfgren Burström A, Edin S,
Eklöf V, Öberg Å, Stenling R, Palmqvist R and Wikberg ML: SOX2
expression is regulated by BRAF and contributes to poor patient
prognosis in colorectal cancer. PLoS One. 9:e1019572014. View Article : Google Scholar : PubMed/NCBI
|
23
|
Yang F, Gao Y, Geng J, Qu D, Han Q, Qi J
and Chen G: Elevated expression of SOX2 and FGFR1 in correlation
with poor prognosis in patients with small cell lung cancer. Int J
Clin Exp Pathol. 6:2846–2854. 2013.PubMed/NCBI
|
24
|
Forghanifard MM, Ardalan Khales S,
Javdani-Mallak A, Rad A, Farshchian M and Abbaszadegan MR: Stemness
state regulators SALL4 and SOX2 are involved in progression and
invasiveness of esophageal squamous cell carcinoma. Med Oncol.
31:9222014. View Article : Google Scholar : PubMed/NCBI
|
25
|
Wang S, Tie J, Wang R, Hu F, Gao L, Wang
W, Wang L, Li Z, Hu S, Tang S, et al: SOX2, a predictor of survival
in gastric cancer, inhibits cell proliferation and metastasis by
regulating PTEN. Cancer Lett. 358:210–219. 2015. View Article : Google Scholar : PubMed/NCBI
|
26
|
Otsubo T, Akiyama Y, Hashimoto Y, Shimada
S, Goto K and Yuasa Y: MicroRNA-126 inhibits SOX2 expression and
contributes to gastric carcinogenesis. PLoS One. 6:e166172011.
View Article : Google Scholar : PubMed/NCBI
|
27
|
Chen Y, Huang Y, Huang Y, Chen J, Wang S
and Zhou J: The prognostic value of SOX2 expression in non-small
cell lung cancer: A meta-analysis. PLoS One. 8:e711402013.
View Article : Google Scholar : PubMed/NCBI
|
28
|
Thu KL, Becker-Santos DD, Radulovich N,
Pikor LA, Lam WL and Tsao MS: SOX15 and other SOX family members
are important mediators of tumorigenesis in multiple cancer types.
Oncoscience. 1:326–335. 2014. View Article : Google Scholar : PubMed/NCBI
|
29
|
Huang W, Chen Z, Shang X, Tian D, Wang D,
Wu K, Fan D and Xia L: Sox12, a direct target of FoxQ1, promotes
hepatocellular carcinoma metastasis through up-regulating Twist1
and FGFBP1. Hepatology. 61:1920–1933. 2015. View Article : Google Scholar : PubMed/NCBI
|
30
|
Duquet A, Melotti A, Mishra S, Malerba M,
Seth C, Conod A and Ruiz i Altaba A: A novel genome-wide in vivo
screen for metastatic suppressors in human colon cancer identifies
the positive WNT-TCF pathway modulators TMED3 and SOX12. EMBO Mol
Med. 6:882–901. 2014. View Article : Google Scholar : PubMed/NCBI
|
31
|
Yan HT, Shinka T, Sato Y, Yang XJ, Chen G,
Sakamoto K, Kinoshita K, Aburatani H and Nakahori Y: Overexpression
of SOX15 inhibits proliferation of NT2/D1 cells derived from a
testicular embryonal cell carcinoma. Mol Cells. 24:323–328.
2007.PubMed/NCBI
|
32
|
Thu KL, Radulovich N, Becker-Santos DD,
Pikor LA, Pusic A, Lockwood WW, Lam WL and Tsao MS: SOX15 is a
candidate tumor suppressor in pancreatic cancer with a potential
role in Wnt/β-catenin signaling. Oncogene. 33:279–288. 2014.
View Article : Google Scholar : PubMed/NCBI
|